See the DrugPatentWatch profile for Alendronate
Alendronate is a bisphosphonate medication used to treat and prevent osteoporosis in postmenopausal women and in men. It is also prescribed to treat Paget's disease of bone and glucocorticoid-induced osteoporosis [1].
How does alendronate work?
Alendronate works by slowing down bone loss, which is a process called bone resorption. It achieves this by inhibiting osteoclasts, the cells responsible for breaking down bone tissue. By reducing bone resorption, alendronate helps to increase bone mineral density and reduce the risk of fractures [1].
What are the common side effects of alendronate?
Common side effects of alendronate can include gastrointestinal issues such as heartburn, difficulty swallowing, and stomach pain. Some patients may also experience nausea, diarrhea, or bloating. Other potential side effects include headache, dizziness, and musculoskeletal pain [1].
What are the serious risks associated with alendronate?
Serious but rare side effects of alendronate include esophageal irritation or ulceration, osteonecrosis of the jaw (bone death in the jawbone), and atypical fractures of the thigh bone. Patients are advised to report any new or worsening bone pain, jaw pain, or difficulty swallowing immediately to their healthcare provider [1].
How is alendronate taken?
Alendronate is typically taken once a day or once a week. It is crucial to take the medication on an empty stomach with a full glass of plain water, at least 30 minutes before the first food, drink, or other medication of the day. Patients should remain upright for at least 30 minutes after taking alendronate and for 30 minutes after their first food of the day to reduce the risk of esophageal irritation [1].
What is the typical dosage for alendronate?
The typical dosage for alendronate varies depending on the condition being treated. For osteoporosis, the usual dose is 10 mg once daily or 70 mg once weekly. For Paget's disease, the dose is typically 40 mg once daily [1].
How long does it take for alendronate to become effective?
The effects of alendronate on bone density can be observed over time, with significant improvements in bone mineral density typically seen after several months of consistent use. The full therapeutic benefit, including fracture risk reduction, is assessed over longer treatment periods [1].
What are alternatives to alendronate for osteoporosis?
Other medications used to treat osteoporosis include other bisphosphonates like risedronate and ibandronate, as well as denosumab, teriparatide, abaloparatide, and hormone replacement therapy. The choice of treatment depends on individual patient factors, including medical history and fracture risk [2].
When does the patent for alendronate expire?
Alendronate, marketed primarily as Fosamax, has been available as a generic medication for many years. The original patents for alendronate have long expired, allowing for the production and sale of generic versions by multiple pharmaceutical companies [3]. Information on specific patent expiries for brand-name drugs can be found on DrugPatentWatch.com [4].